Based on these data, we propose that during melanoma tumor progression, EPAC-RAP1 signaling axis acts to switch cAMP signaling from a pro-proliferative signal in primary melanoma to an anti-proliferative signal in metastatic melanoma. Here, RAPGEF4 is linked to melanoma.